KAM
WX

Kassirer Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Kassirer Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-35,000
Closed -$1.51M – 73
2015
Q3 		$1.51M Buy
+35,000
New +$1.48M 1.01% 30

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Kassirer Asset Management's WX Position: Q4 2015 in Review

Kassirer Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 35,000 shares — an estimated $1.51M sold.

Kassirer Asset Management first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $1.51M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Kassirer Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Kassirer Asset Management sold 35,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.51M.
  • Kassirer Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
  • Kassirer Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.51M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Kassirer Asset Management's 13F filing for Q4 2015, filed 27 Jan 2016.